Diabetes Insipidus Medication

1. Earley LE, Orloff J. The mechanism of antidiuresis associated with the administration of hydrochlorothiazide to patients with vasopressin-resistant diabetes insipidus. J Clin Invest. Nov 1962;41(11):1988-97.

2. Knoers N, Lemmink H, Adam MP, et al. Hereditary Nephrogenic Diabetes Insipidus. GeneReviews. Updated 2020 Feb 27. [QxMD MEDLINE Link]. [Full Text].

3. Babey M, Kopp P, Robertson GL. Familial forms of diabetes insipidus: clinical and molecular characteristics. Nat Rev Endocrinol. 2011 Jul 5. 7(12):701-14. [QxMD MEDLINE Link].

4. Bockenhauer D, van't Hoff W, Dattani M, Lehnhardt A, Subtirelu M, Hildebrandt F, et al. Secondary nephrogenic diabetes insipidus as a complication of inherited renal diseases. Nephron Physiol. 2010. 116(4):p23-9. [QxMD MEDLINE Link].

5. Los EL, Deen PM, Robben JH. Potential of nonpeptide (ant)agonists to rescue vasopressin V2 receptor mutants for the treatment of X-linked nephrogenic diabetes insipidus. J Neuroendocrinol. 2010 May. 22(5):393-9. [QxMD MEDLINE Link].

6. Rochdi MD, Vargas GA, Carpentier E, Oligny-Longpré G, et al. Functional characterization of vasopressin type 2 receptor substitutions (R137H/C/L) leading to nephrogenic diabetes insipidus and nephrogenic syndrome of inappropriate antidiuresis: implications for treatments. Mol Pharmacol. 2010 May. 77(5):836-45. [QxMD MEDLINE Link]. [Full Text].

7. Hadjizacharia P, Beale EO, Inaba K, Chan LS, Demetriades D. Acute diabetes insipidus in severe head injury: a prospective study. J Am Coll Surg. 2008 Oct. 207(4):477-84. [QxMD MEDLINE Link].

8. Andereggen L, Hess B, Andres R, et al. A ten-year follow-up study of treatment outcome of craniopharyngiomas. Swiss Med Wkly. 2018 Feb 14. 148:w14521. [QxMD MEDLINE Link].

9. Tanji M, Mineharu Y, Kikuchi M, et al. Intraoperative Cerebrospinal Fluid Leak Graded by Esposito Grade Is a Predictor for Diabetes Insipidus After Endoscopic Endonasal Pituitary Adenoma Resection. World Neurosurg. 2021 Nov 27. [QxMD MEDLINE Link].

10. Saldarriaga C, Lyssikatos C, Belyavskaya E, et al. Postoperative Diabetes Insipidus and Hyponatremia in Children after Transsphenoidal Surgery for Adrenocorticotropin Hormone and Growth Hormone Secreting Adenomas. J Pediatr. 2018 Jan 30. [QxMD MEDLINE Link].

11. Kristof RA, Rother M, Neuloh G, Klingmüller D. Incidence, clinical manifestations, and course of water and electrolyte metabolism disturbances following transsphenoidal pituitary adenoma surgery: a prospective observational study. J Neurosurg. 2009 Sep. 111(3):555-62. [QxMD MEDLINE Link].

12. Seckl J, Dunger D. Postoperative diabetes insipidus. BMJ. 1989 Jan 7. 298(6665):2-3. [QxMD MEDLINE Link]. [Full Text].

13. Hannon MJ, Sherlock M, Thompson CJ. Pituitary dysfunction following traumatic brain injury or subarachnoid haemorrhage - in "Endocrine Management in the Intensive Care Unit". Best Pract Res Clin Endocrinol Metab. 2011 Oct. 25(5):783-98. [QxMD MEDLINE Link].

14. Schneider HJ, Kreitschmann-Andermahr I, Ghigo E, Stalla GK, Agha A. Hypothalamopituitary dysfunction following traumatic brain injury and aneurysmal subarachnoid hemorrhage: a systematic review. JAMA. 2007 Sep 26. 298(12):1429-38. [QxMD MEDLINE Link].

15. Fujiwara TM, Bichet DG. Molecular biology of hereditary diabetes insipidus. J Am Soc Nephrol. 2005 Oct. 16(10):2836-46. [QxMD MEDLINE Link].

16. Hedrich CM, Zachurzok-Buczynska A, Gawlik A, Russ S, Hahn G, Koehler K, et al. Autosomal dominant neurohypophyseal diabetes insipidus in two families. Molecular analysis of the vasopressin-neurophysin II gene and functional studies of three missense mutations. Horm Res. 2009. 71(2):111-9. [QxMD MEDLINE Link].

17. Christensen JH, Rittig S. Familial neurohypophyseal diabetes insipidus--an update. Semin Nephrol. 2006 May. 26(3):209-23. [QxMD MEDLINE Link].

18. Hansen LK, Rittig S, Robertson GL. Genetic basis of familial neurohypophyseal diabetes insipidus. Trends Endocrinol Metab. 1997 Nov. 8(9):363-72. [QxMD MEDLINE Link].

19. Rigoli L, Lombardo F, Di Bella C. Wolfram syndrome and WFS1 gene. Clin Genet. 2011 Feb. 79(2):103-17. [QxMD MEDLINE Link].

20. Lee DH, Lee BK, Song KH, et al. Prevalence and risk factors for central diabetes insipidus in cardiac arrest survivor treated with targeted temperature management. Am J Emerg Med. 2016 Apr 8. [QxMD MEDLINE Link].

21. Trepiccione F, Christensen BM. Lithium-induced nephrogenic diabetes insipidus: new clinical and experimental findings. J Nephrol. 2010 Nov-Dec. 23 Suppl 16:S43-8. [QxMD MEDLINE Link].

22. Verkman AS. Aquaporins in clinical medicine. Annu Rev Med. 2012. 63:303-16. [QxMD MEDLINE Link]. [Full Text].

23. Spanakis E, Milord E, Gragnoli C. AVPR2 variants and mutations in nephrogenic diabetes insipidus: review and missense mutation significance. J Cell Physiol. 2008 Dec. 217(3):605-17. [QxMD MEDLINE Link].

24. Satoh M, Ogikubo S, Yoshizawa-Ogasawara A. Correlation between clinical phenotypes and X-inactivation patterns in six female carriers with heterozygote vasopressin type 2 receptor gene mutations. Endocr J. 2008 May. 55(2):277-84. [QxMD MEDLINE Link].

25. Saborio P, Tipton GA, Chan JC. Diabetes insipidus. Pediatr Rev. 2000 Apr. 21(4):122-9; quiz 129. [QxMD MEDLINE Link].

26. Verkman AS. Aquaporins in clinical medicine. Annu Rev Med. 2012. 63:303-16. [QxMD MEDLINE Link]. [Full Text].

27. D'Alessandri-Silva C, Carpenter M, Ayoob R, et al. Diagnosis, Treatment, and Outcomes in Children With Congenital Nephrogenic Diabetes Insipidus: A Pediatric Nephrology Research Consortium Study. Front Pediatr. 2019. 7:550. [QxMD MEDLINE Link].

28. Ananthakrishnan S. Diabetes insipidus during pregnancy. Best Pract Res Clin Endocrinol Metab. 2016 Mar. 30 (2):305-15. [QxMD MEDLINE Link].

29. Masri-Iraqi H, Hirsch D, Herzberg D, et al. CENTRAL DIABETES INSIPIDUS: CLINICAL CHARACTERISTICS AND LONG-TERM COURSE IN A LARGE COHORT OF ADULTS. Endocr Pract. 2017 Feb 22. [QxMD MEDLINE Link].

30. Winzeler B, Cesana-Nigro N, Refardt J, et al. Arginine-stimulated copeptin measurements in the differential diagnosis of diabetes insipidus: a prospective diagnostic study. Lancet. 2019 Aug 17. 394 (10198):587-95. [QxMD MEDLINE Link].

31. Gilman A, Goodman L. The secretory response of the posterior pituitary to the need for water conservation. J Physiol. 1937 Jul 15;90(2):113-24.

32. Di Iorgi N, Napoli F, Allegri AE, Olivieri I, Bertelli E, Gallizia A, et al. Diabetes insipidus--diagnosis and management. Horm Res Paediatr. 2012. 77(2):69-84. [QxMD MEDLINE Link].

33. Zerbe RL, Robertson GL. A comparison of plasma vasopressin measurements with a standard indirect test in the differential diagnosis of polyuria. N Engl J Med. 1981 Dec 24. 305(26):1539-46. [QxMD MEDLINE Link].

34. Li G, Shao P, Sun X, Wang Q, Zhang L. Magnetic resonance imaging and pituitary function in children with panhypopituitarism. Horm Res Paediatr. 2010. 73(3):205-9. [QxMD MEDLINE Link].

35. Krahulik D, Zapletalova J, Frysak Z, Vaverka M. Dysfunction of hypothalamic-hypophysial axis after traumatic brain injury in adults. J Neurosurg. 2010 Sep. 113(3):581-4. [QxMD MEDLINE Link].

36. Wang S, Li D, Ni M, et al. Clinical predictors of diabetes insipidus after transcranial surgery for pituitary adenoma. World Neurosurg. 2017 Jan 30. [QxMD MEDLINE Link].

37. Richardson DW, Robinson AG. Desmopressin. Ann Intern Med. 1985 Aug. 103(2):228-39. [QxMD MEDLINE Link].

38. Schrier RW. Systemic arterial vasodilation, vasopressin, and vasopressinase in pregnancy. J Am Soc Nephrol. 2010 Apr. 21(4):570-2. [QxMD MEDLINE Link].

39. Vande Walle J, Stockner M, Raes A, Nørgaard JP. Desmopressin 30 years in clinical use: a safety review. Curr Drug Saf. 2007 Sep. 2(3):232-8. [QxMD MEDLINE Link].

40. Ausiello JC, Bruce JN, Freda PU. Postoperative assessment of the patient after transsphenoidal pituitary surgery. Pituitary. 2008. 11(4):391-401. [QxMD MEDLINE Link].

41. Pratheesh R, Swallow DM, Rajaratnam S, Jacob KS, Chacko G, Joseph M, et al. Incidence, predictors and early post-operative course of diabetes insipidus in paediatric craniopharygioma: a comparison with adults. Childs Nerv Syst. 2013 Feb 6. [QxMD MEDLINE Link].

Romesh Khardori, MD, PhD, FACP (Retired) Professor, Division of Endocrinology, Diabetes and Metabolism, Department of Internal Medicine, Eastern Virginia Medical School

Romesh Khardori, MD, PhD, FACP is a member of the following medical societies: American Association of Clinical Endocrinologists, American College of Physicians, American Diabetes Association, Endocrine Society

Disclosure: Nothing to disclose.

Jagdeesh Ullal, MD, MS, FACE, FACP, ECNU Clinical Associate Professor of Medicine (Endocrinology and Metabolism), Clinic Lead for Inpatient and Subspecialty Diabetes, UPMC Center for Diabetes and Endocrinology, University of Pittsburgh Medical Center

Jagdeesh Ullal, MD, MS, FACE, FACP, ECNU is a member of the following medical societies: American Medical Association, International Society for Clinical Densitometry, Medical Society of Virginia

Disclosure: Nothing to disclose.

Michael Cooperman, MD Former (Retired) Division Head of Endocrinology, Jeannes Hospital

Michael Cooperman, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Physicians, American Association of Clinical Endocrinologists, Endocrine Society

Disclosure: Nothing to disclose.

George T Griffing, MD Professor Emeritus of Medicine, St Louis University School of Medicine

George T Griffing, MD is a member of the following medical societies: American Association for Physician Leadership, American Association for the Advancement of Science, American College of Medical Practice Executives, American College of Physicians, American Diabetes Association, American Federation for Medical Research, American Heart Association, Central Society for Clinical and Translational Research, Endocrine Society, International Society for Clinical Densitometry, Southern Society for Clinical Investigation

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Frederick H Ziel, MD Associate Professor of Medicine, University of California, Los Angeles, David Geffen School of Medicine; Physician-In-Charge, Endocrinology/Diabetes Center, Director of Medical Education, Kaiser Permanente Woodland Hills; Chair of Endocrinology, Co-Chair of Diabetes Complete Care Program, Southern California Permanente Medical Group

Frederick H Ziel, MD is a member of the following medical societies: American Association of Clinical Endocrinologists, American College of Endocrinology, American College of Physicians, American College of Physicians-American Society of Internal Medicine, American Diabetes Association, American Federation for Medical Research, American Medical Association, American Society for Bone and Mineral Research, California Medical Association, Endocrine Society, andInternational Society for Clinical Densitometry

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article